Filing Details

Accession Number:
0001543407-15-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-02 17:05:05
Reporting Period:
2015-06-01
Filing Date:
2015-06-02
Accepted Time:
2015-06-02 17:05:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
10795 Becton Dickinson & Co BDX Surgical & Medical Instruments & Apparatus (3841) 220760120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532277 Stephen Sichak C/O Becton, Dickinson And Company
1 Becton Drive
Franklin Lakes NJ 07417
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-01 3,659 $140.95 10,541 No 4 S Direct
Common Stock Acquisiton 2015-06-01 7,116 $62.50 17,657 No 4 M Direct
Common Stock Disposition 2015-06-01 3,155 $140.94 14,502 No 4 D Direct
Common Stock Disposition 2015-06-01 3,961 $140.94 10,541 No 4 S Direct
Common Stock Acquisiton 2015-06-01 9,854 $75.63 20,395 No 4 M Direct
Common Stock Disposition 2015-06-01 5,286 $140.94 15,109 No 4 D Direct
Common Stock Disposition 2015-06-01 4,568 $140.94 10,541 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2015-06-01 7,116 $0.00 7,116 $62.50
Common Stock Stock Appreciation Rights Disposition 2015-06-01 9,854 $0.00 9,854 $75.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-11-25 2018-11-25 No 4 M Direct
0 2010-11-24 2019-11-24 No 4 M Direct
Footnotes
  1. The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $140.87 through $141.12. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
  2. The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $140.86 through $141.12. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
  3. The stock appreciation rights vest in four annual installments beginning November 25, 2009.
  4. The stock appreciation rights vest in four annual installments beginning November 24, 2010.